FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

27957311000001103: Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87537501000001111 Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
87537601000001110 Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
106881801000001110 Lansoprazole 15mg orodispersible tablets (Lupin Healthcare (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Is a Lansoprazole 15mg orodispersible gastro-resistant tablets true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has specific active ingredient Lansoprazole true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) 28 tablet Has AMP True Lansoprazole 15mg orodispersible tablets (Lupin (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start